RT @umnneurosurgery: Comparative Effectiveness of Intracerebroventricular, Intrathecal, and Intranasal Routes of AAV9 Vector Administration…
Comparative Effectiveness of Intracerebroventricular, Intrathecal, and Intranasal Routes of AAV9 Vector Administration for Genetic Therapy of Neurologic Disease in Murine Mucopolysaccharidosis Type I | Co-author: Dr. Walter Low | https://t.co/rPDJdsXwOY
Comparative Effectiveness of Intracerebroventricular, Intrathecal, and Intranasal Routes of AAV9 Vector Administration for Genetic Therapy of Neurologic Disease in Murine Mucopolysaccharidosis Type I https://t.co/Su8s3ZFRtc https://t.co/M4x7Z9Zrni
Nouvelle recherche: efficacité comparative des voies intracérébroventriculaire, intrathécale et intranasale de l'administration de vecteurs AAV9 pour la thérapie génétique des maladies neurologiques dans la mucopolysaccharidose murine de type I:…Frontiers